PDL BIOPHARMA, INC.·4

Dec 17, 4:49 PM ET

Stone Christopher Lewis 4

4 · PDL BIOPHARMA, INC. · Filed Dec 17, 2020

Insider Transaction Report

Form 4
Period: 2020-12-16
Stone Christopher Lewis
VP and General Counsel
Transactions
  • Sale

    Common stock

    2020-12-16$2.56/sh200,000$512,000405,559 total

Documents

1 file
  • 4
    wf-form4_160824173910716.xmlPrimary

    FORM 4